<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-molecules-24-02603">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kodama</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kohgo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kitano</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Machida</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Gatanaga</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Shigeta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Matsuoka</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ohrui</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Mitsuya</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>4â€²-Ethynyl nucleoside analogs: Potent inhibitors of multidrug-resistant human immunodeficiency virus variants 
   <italic>in vitro</italic>
  </article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2001</year>
  <volume>45</volume>
  <fpage>1539</fpage>
  <lpage>1546</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.45.5.1539-1546.2001</pub-id>
  <?supplied-pmid 11302824?>
  <pub-id pub-id-type="pmid">11302824</pub-id>
 </element-citation>
</ref>
